C6K Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Avalo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.488 EUR 3.15% Market Closed

Market Cap: €238.9m

	Avalo Therapeutics Inc F:C6K	US
	Cemex SAB de CV NYSE:CX	MX
B	Bridgestone Corp XMUN:BGT	JP
G	Globant SA LSE:0RIX	LU
E	EDP Renovaveis SA XMUN:EDW	ES
	United Utilities Group PLC LSE:UU	UK
	Dominion Energy Inc NYSE:D	US
D	Discover Financial Services DUS:DC7	US
C	Costco Wholesale Corp DUS:CTO	US
W	WEX Inc F:WL9	US
M	Manulife Financial Corp XBER:MLU	CA
	Danone SA F:BSND	FR
L	Lloyds Banking Group PLC SWB:LLD	UK
D	DTE Energy Co F:DGY	US
	Shoprite Holdings Ltd F:HY7A	ZA

Profitability Summary

Avalo Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

105%

Gross Margin is Increasing

81% > 100%

Negative Operating Margin

-123 602%

Negative 3Y Average Operating Margin

-18 716%

Declining Operating Margin

-146% > -123 602%

Negative Net Margin

-132 642%

Negative 3Y Average Net Margin

-21 305%

Declining Net Margin

-170% > -132 642%

Negative Free Cash Flow Margin

-87 217%

Negative 3Y Average Free Cash Flow Margin

-14 686%

Declining Free Cash Flow Margin

-121% > -87 217%

Negative ROE

-72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-281%

Declining ROIC

-151% > -428%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.